Krouzon Pharmaceuticals
Manufacturing · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
290 Congress Ave, New Haven, Connecticut...Website
www.krouzon.comRevenue
<$5 MillionIndustry
About Krouzon Pharmaceuticals
Krouzon Pharmaceuticals, Inc. specializes in developing therapeutics for children affected by FGFR2-related Craniosynostosis Syndromes. Founded by Dr. V.P. Eswarakumar, the company is known for creating the world's first disease model for Crouzon and Pfeiffer syndromes. With a dedicated team of Ph.D. level scientists, Krouzon aims to restore normal child development without the need for lifelong surgeries. The company is privately held and managed by experienced professionals passionate about advancing pediatric healthcare.Explore more
SIC Code 28,283NAICS Code 32,325Show moreKrouzon Pharmaceuticals Org Chart
Compare Similar Companies to Krouzon Pharmaceuticals
Compare insights from companies similar to Krouzon Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Krouzon Pharmaceuticals Tech Stack
A closer look at the technologies used by Krouzon Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Krouzon Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Krouzon Pharmaceuticals, Inc. specializes in developing therapeutics for children affected by FGFR2-related Craniosynostosis Syndromes. Founded by Dr. V.P. Eswarakumar, the company is known for creating the world's first disease model for Crouzon and Pfeiffer syndromes. With a dedicated team of Ph.D. level scientists, Krouzon aims to restore normal... Read More